On The Pen: The Weekly Dose 5.7.24

MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join 
Venmo: OnThePen 
Ca$h App: ManOnMounjaro 

SOCIAL LINKS 
https://www.tiktok.com/@manonthemounjaro 
https://twitter.com/ManOnMounjaro 
https://instagram.com/manonthemounjaro 
https://facebook.com/manonthemounjaro 

#Zepbound #Maritide #mounjaro 

LINKS 
Life Update Blog: Link: https://www.onthepen.com/post/i-m-tired-we-are-tired 

Wegovy released in Canada: 
Link: https://www.msn.com/en-ca/health/other/weight-loss-drug-wegovy-available-in-canada-starting-may-6/ar-AA1o1lZz 

Madison Muller at Bloomberg (friend of our community) had article "Why Weight-Loss Drugs Wegovy, Zepbound Are in Short Supply" 
Link: https://www.bloomberg.com/news/articles/2024-05-02/why-weight-loss-drugs-wegovy-zepbound-are-facing-shortages?srnd=undefined&embedded-checkout=true 

Interviewed on radio station KXEL 
Link: https://www.youtube.com/watch?v=V0YyMwtMuxs 

Optum RX Irony alert: 
Link: https://www.managedhealthcareexecutive.com/view/glp-1-tiering-agreement-reached-says-optum-rx-president 

FTC is challenging Novo Nordisk's patents on Ozempic 
Link: https://www.ftc.gov/system/files/ftc_gov/pdf/novo-nordisk-ozempic-saxenda-victoza-_4302024.pdf 

FTC requested additional information on Novo Nordisk's acquisition of Catalent: 
Link: https://www.msn.com/en-us/money/markets/us-ftc-seeks-more-information-on-novo-nordisk-parent-catalent-deal/ar-AA1o6gHU